Trial Profile
A prospective study to assess and manage drug compliance of dabigatran etexilate in atrial fibrillation patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Apr 2016
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Thromboembolism
- Focus Pharmacokinetics; Therapeutic Use
- 05 Apr 2016 New trial record